RSS

Netherlands Cancer Institute

The Netherlands Cancer Institute (NKI) has granted exclusive worldwide licensing rights for its web tool, TIDE — Tracking of Indels by DEcomposition — to biotech company, Desktop Genetics (DTG). Read more

Technology

A new strategy to tackle the issue of long-term treatment efficacy in cancer patients has been developed by researchers from the Netherlands Cancer Institute in collaboration with international biotechnology company, Genmab. Read more

News

The Netherlands Cancer Institute (NKI) is the recipient of funds from the Dutch Cancer Society (KWF Kankerbestrijding) to apply molecular imaging technology to guide prostate cancer surgery, it has been announced. Read more

Technology

A research team from the Netherlands Cancer Institute has discovered the underlying mechanism to why cancer cells become addicted to the drugs that are administered to kill them, which may lead to more rational alternating therapies. Read more

News